FDA: Letter to the Industry on COVID-19
March 26, 2020
The FDA has written a letter addressed to medical device establishments in order to address the impact of the COVID-19 pandemic on day-to-day operations in the FDA’s Center for Devices and Radiological Health (CDRH) and in the medical device industry.
Recent News
- Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
- Connecting with Life Sciences in Logan
- Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- Ratio Therapeutics Enters into Research Collaboration, License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
- Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
